tiprankstipranks
Icecure Medical Ltd. (ICCM)
NASDAQ:ICCM
US Market

Icecure Medical (ICCM) Stock Statistics & Valuation Metrics

294 Followers

Total Valuation

Icecure Medical has a market cap or net worth of $20.72M. The enterprise value is $13.99M.
Market Cap$20.72M
Enterprise Value$13.99M

Share Statistics

Icecure Medical has 68,693,054 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding68,693,054
Owned by Insiders
Owned by Institutions

Financial Efficiency

Icecure Medical’s return on equity (ROE) is -1.66 and return on invested capital (ROIC) is -162.86%.
Return on Equity (ROE)-1.66
Return on Assets (ROA)-1.08
Return on Invested Capital (ROIC)-162.86%
Return on Capital Employed (ROCE)-1.67
Revenue Per Employee52.80K
Profits Per Employee-235.27K
Employee Count64
Asset Turnover0.24
Inventory Turnover0.86

Valuation Ratios

The current PE Ratio of Icecure Medical is ―. Icecure Medical’s PEG ratio is 0.13.
PE Ratio
PS Ratio11.48
PB Ratio4.29
Price to Fair Value4.29
Price to FCF-2.66
Price to Operating Cash Flow-1.60
PEG Ratio0.13

Income Statement

In the last 12 months, Icecure Medical had revenue of 3.38M and earned -15.06M in profits. Earnings per share was -0.24.
Revenue3.38M
Gross Profit1.11M
Operating Income-15.09M
Pretax Income-15.06M
Net Income-15.06M
EBITDA-14.80M
Earnings Per Share (EPS)-0.24

Cash Flow

In the last 12 months, operating cash flow was -15.02M and capital expenditures -36.77K, giving a free cash flow of -15.06M billion.
Operating Cash Flow-15.02M
Free Cash Flow-15.06M
Free Cash Flow per Share-0.22

Dividends & Yields

Icecure Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta-0.09
52-Week Price Change-71.33%
50-Day Moving Average0.57
200-Day Moving Average0.79
Relative Strength Index (RSI)24.06
Average Volume (3m)627.74K

Important Dates

Icecure Medical upcoming earnings date is Jun 3, 2026, Before Open (Confirmed).
Last Earnings DateMar 17, 2026
Next Earnings DateJun 3, 2026
Ex-Dividend Date

Financial Position

Icecure Medical as a current ratio of 2.61, with Debt / Equity ratio of 2.40%
Current Ratio2.61
Quick Ratio2.07
Debt to Market Cap<0.01
Net Debt to EBITDA0.59
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Icecure Medical has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00

Enterprise Valuation

Icecure Medical EV to EBITDA ratio is -2.03, with an EV/FCF ratio of -2.06.
EV to Sales8.91
EV to EBITDA-2.03
EV to Free Cash Flow-2.06
EV to Operating Cash Flow-2.07

Balance Sheet

Icecure Medical has $8.90M in cash and marketable securities with $217.00K in debt, giving a net cash position of $8.68M billion.
Cash & Marketable Securities$8.90M
Total Debt$217.00K
Net Cash$8.68M
Net Cash Per Share$0.13
Tangible Book Value Per Share$0.14

Margins

Gross margin is 36.28%, with operating margin of -446.70%, and net profit margin of -445.61%.
Gross Margin36.28%
Operating Margin-446.70%
Pretax Margin-445.61%
Net Profit Margin-445.61%
EBITDA Margin-437.97%
EBIT Margin-446.70%

Analyst Forecast

The average price target for Icecure Medical is $3.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$3.00
Price Target Upside248.84% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-18.96%
EPS Growth Forecast8.98%

Scores

Smart ScoreN/A
AI Score